CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $97,971 | +444.3% | 33,900 | +2265.7% | 0.00% | – |
| Q1 2021 | $18,000 | -72.7% | 1,433 | -72.3% | 0.00% | – |
| Q4 2020 | $66,000 | +120.0% | 5,173 | +171.1% | 0.00% | – |
| Q3 2020 | $30,000 | -52.4% | 1,908 | -31.8% | 0.00% | – |
| Q2 2020 | $63,000 | +800.0% | 2,798 | +446.5% | 0.00% | – |
| Q1 2020 | $7,000 | -85.7% | 512 | -83.4% | 0.00% | – |
| Q4 2019 | $49,000 | +157.9% | 3,078 | +31.3% | 0.00% | – |
| Q3 2019 | $19,000 | -5.0% | 2,344 | +7.4% | 0.00% | – |
| Q2 2019 | $20,000 | +300.0% | 2,183 | +247.1% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 629 | -28.0% | 0.00% | – |
| Q4 2018 | $4,000 | +300.0% | 874 | +616.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 122 | -3.2% | 0.00% | – |
| Q2 2018 | $1,000 | – | 126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |